RESPIRATORY PHYSIOLOGY

Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study

S Kony, M Zureik, F Driss, C Neukirch, B Leynaert, F Neukirch

National Institute of Health and Medical Research (INSERM), Unit 408 Respiratory Diseases Epidemiology, Paris; INSERM, Unit 508, Lille; and Bichat Teaching Hospital, Biochemistry B, Paris, France

Correspondence to:
Correspondence to:
S Kony PhD
INSERM U408, Epidémiologie des Maladies Respiratoires, Faculté Xavier Bichat, 16 rue Henri Huchard, 75018 Paris, France; kony{at}bichat.inserm.fr

Background: C-reactive protein (CRP), a marker of systemic inflammation, is a powerful predictor of adverse cardiovascular events. Respiratory impairment is also associated with cardiovascular risk. Although some studies have found an inverse relationship between lung function and markers of systemic inflammation, only one study has reported a relationship between lung function and CRP levels. In contrast, little is known about the relationship between bronchial hyperresponsiveness (BHR) and systemic inflammation. The association between lung function and CRP and between BHR and CRP has been investigated.

Methods: As part of the European Community Respiratory Health Survey follow up study serum CRP levels, forced expiratory volume in 1 second (FEV₁), and BHR to methacholine (20% decrease in FEV₁ to <4 mg methacholine) were measured in 259 adults aged 28–56 years free of cardiovascular disease or respiratory infection.

Results: Mean (SD) FEV₁ (adjusted for age, sex, height, and smoking status) was lower in subjects with a high CRP level (high tertile) (3.29 (0.44) l/s v 3.50 (0.44) l/s; p<0.001) and BHR was more frequent (41.9% v 24.9%; p = 0.005) than in subjects with lower CRP levels (low+middle tertiles). Similar results were obtained when the potential confounding factors were taken into account. Similar patterns of results were found in non-smokers and in non-asthmatic subjects.

Conclusions: Increased CRP levels are strongly and independently associated with respiratory impairment and more frequent BHR. These results suggest that both respiratory impairment and BHR are associated with a systemic inflammatory process.

Abbreviations: BHR, bronchial hyperresponsiveness; CRP, C-reactive protein; FEV₁, forced expiratory volume in 1 second; FVC, forced vital capacity

Keywords: bronchial hyperresponsiveness; C-reactive protein; lung function

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Airwaves

Wisia Wedzicha
Thorax 2004 59: 821a. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Thyagarajan, B., Smith, L. J., Barr, R. G., Gross, M. D., Sood, A., Kalhan, R., Jacobs, D. R. Jr (2009). Association of Circulating Adhesion Molecules With Lung Function: The CARDIA Study. Chest 135: 1481-1487 [Abstract] [Full Text]  
• Rasmussen, F., Mikkelsen, D., Hancox, R. J., Lambrechtsen, J., Nybo, M., Hansen, H. S., Siersted, H. C. (2009). High-sensitive C-reactive protein is associated with reduced lung function in young adults. Eur Respir J 33: 382-388 [Abstract] [Full Text]  
• Lee, H. M., Le, T. V., Lopez, V. A., Wong, N. D. (2008). Association of C-Reactive Protein With Reduced Forced Vital Capacity in a Nonsmoking U.S. Population With Metabolic Syndrome and Diabetes. Diabetes Care 31: 2000-2002 [Abstract] [Full Text]  
• Jiang, R., Burke, G. L., Enright, P. L., Newman, A. B., Margolis, H. G., Cushman, M., Tracy, R. P., Wang, Y., Kronmal, R. A., Barr, R. G. (2008). Inflammatory Markers and Longitudinal Lung Function Decline in the Elderly. Am J Epidemiol 168: 602-610 [Abstract] [Full Text]  
• Butland, B. K., Strachan, D. P., Rudnicka, A. R. (2008). C-reactive protein, obesity, atopy and asthma symptoms in middle-aged adults. Eur Respir J 32: 77-84 [Abstract] [Full Text]  
• Sunyer, J., Pistelli, R., Plana, E., Andreani, M., Baldari, F., Kolz, M., Koenig, W., Pekkanen, J., Peters, A., Forastiere, F. (2008). Systemic inflammation, genetic susceptibility and lung function. Eur Respir J 32: 92-97 [Abstract] [Full Text]  
• Lofdahl, C-G., Postma, D. S., Pride, N. B., Boe, J., Thoren, A. (2007). Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD. Eur Respir J 29: 1115-1119 [Abstract] [Full Text]  
• Fogarty, A. W, Jones, S., Britton, J. R, Lewis, S. A, McKeever, T. M (2007). Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 62: 515-520 [Abstract] [Full Text]  
• Mahler, D. A (2007). Is physical activity anti-inflammatory on the airways?. Thorax 62: 376-376 [Full Text]  
• Shaaban, R., Leynaert, B., Soussan, D., Anto, J. M, Chinn, S., de Marco, R., Garcia-Aymerich, J., Heinrich, J., Janson, C., Jarvis, D., Sunyer, J., Svanes, C., Wjst, M., Burney, P. G, Neukirch, F., Zureik, M. (2007). Physical activity and bronchial hyperresponsiveness: European Community Respiratory Health Survey II. Thorax 62: 403-410 [Abstract] [Full Text]  
• Dahl, M., Vestbo, J., Lange, P., Bojesen, S. E., Tybjaerg-Hansen, A., Nordestgaard, B. G. (2007). C-reactive Protein As a Predictor of Prognosis in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 175: 250-255 [Abstract] [Full Text]  
• Anderson, G. P. (2006). COPD, asthma and C-reactive protein.. Eur Respir J 27: 874-876 [Full Text]  
• Wouters, E. F. M. (2006). The systemic face of airway diseases: the role of C-reactive protein.. Eur Respir J 27: 877-879 [Full Text]  
• Takemura, M., Matsumoto, H., Niimi, A., Ueda, T., Matsuoka, H., Yamaguchi, M., Jinnai, M., Muro, S., Hirai, T., Ito, Y., Nakamura, T., Mio, T., Chin, K., Mishima, M. (2006). High sensitivity C-reactive protein in asthma.. Eur Respir J 27: 908-912 [Abstract] [Full Text]  
• Asero, V., Mistretta, A., Arcidiacono, G., Polosa, R., Sin, D. D., Gan, W. Q., Man, S. F. P. (2005). The Puzzling Relationship Between Cigarette Smoking, Reduced Respiratory Function, and Systemic Inflammation. Chest 128: 3772-3773 [Full Text]  
• Olafsdottir, I S, Gislason, T, Thjodleifsson, B, Olafsson, I, Gislason, D, Jogi, R, Janson, C (2005). C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax 60: 451-454 [Abstract] [Full Text]  
• Buhl, R., Farmer, S. G. (2005). Future Directions in the Pharmacologic Therapy of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2: 83-93 [Abstract] [Full Text]